NCT05953584 A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke Status RECRUITING Phase PHASE2
NCT05951205 Evaluation of Efficacy and Safety of a Single Dose of Exa-cel in Participants With Severe Sickle Cell Disease, βS/ βC Genotype Status WITHDRAWN Phase PHASE3
NCT05909657 Enablers and Barriers to Hydroxyurea Use for Sickle Cell Disease Jamaica Status UNKNOWN Phase N/A
NCT05905770 Do Alemtuzumab Levels Predict T Cell Chimerism After MSD SCT for SCD? Status RECRUITING Phase N/A
NCT05904093 Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease Status RECRUITING Phase PHASE1
NCT05894161 Efficacy of Designed Exercise Program on Pain and Quality of Sleeping in Patient With Sickle Cell Disease Anemia. Status COMPLETED Phase NA
NCT05861453 Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT05848531 Clonidine With Morphine in Patient Controlled Analgesia Pump in Vaso-Occlusive Crisis in Sickle Cell Disease Patient Status UNKNOWN Phase PHASE4
NCT05837871 Genetic and Haematological Modifiers of SCD Severity in Kaduna State, Northern Nigeria Status UNKNOWN Phase N/A
NCT05833022 Patient Characteristics and Treatment Patterns From Early Crizanlizumab Use in Real-world Setting: Preliminary Analysis From Select Sickle Cell Centers Status COMPLETED Phase N/A
NCT05810181 Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX) Status RECRUITING Phase N/A
NCT05791591 Safety and Efficacy of Orally Administered NUV001 Nutraceutical Supplement in Sickle Cell Disease Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT05789355 Effect of NUV001 Supplementation in Patients Suffering From Sickle Cell Disease (SCD) Status ACTIVE_NOT_RECRUITING Phase NA
NCT05758766 Study on Use of Omega-3 Fatty Acids to Improve Outcomes in Individuals With Sickle Cell Disease Status ACTIVE_NOT_RECRUITING Phase NA
NCT05748717 Arterial Function Parameters and Transcranial Doppler Velocity in Paediatric Patients With Sickle Cell Disease Status RECRUITING Phase N/A